Search

Your search keyword '"Carver, Peggy L"' showing total 185 results
Start Over Author "Carver, Peggy L"
185 results on '"Carver, Peggy L"'

8. Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study

Author

Mejia-Chew, Carlos, primary, Carver, Peggy L, additional, Rutjanawech, Sasinuch, additional, Camargo, Luis F Aranha, additional, Fernandes, Ruan, additional, Belga, Sara, additional, Daniels, Shay Anne, additional, Müller, Nicolas J, additional, Burkhard, Sara, additional, Theodoropoulos, Nicole M, additional, Postma, Douwe F, additional, van Duijn, Pleun J, additional, Fariñas, María Carmen, additional, González-Rico, Claudia, additional, Hand, Jonathan, additional, Lowe, Adam, additional, Bodro, Marta, additional, Vanino, Elisa, additional, Cruz, Ana Fernández, additional, Ramos, Antonio, additional, Makek, Mateja Jankovic, additional, Mjahed, Ribal Bou, additional, Manuel, Oriol, additional, Kamar, Nassim, additional, Calvo-Cano, Antonia, additional, Carrasco, Laura Rueda, additional, Muñoz, Patricia, additional, Rodríguez, Sara, additional, Pérez-Recio, Sandra, additional, Sabé, Núria, additional, Álvarez, Regino Rodríguez, additional, Silva, José Tiago, additional, Mularoni, Alessandra, additional, Vidal, Elisa, additional, Alonso-Titos, Juana, additional, del Rosal, Teresa, additional, Classen, Annika Y, additional, Goss, Charles W, additional, Agarwal, Mansi, additional, and López-Medrano, Francisco, additional

Published
2022
Full Text
View/download PDF

10. Use of Computer-Assisted Instruction to Review Microbiology and Antimicrobial Agents.

Author

Carver, Peggy L.

Abstract

A study assessed the effectiveness of a microcomputer-assisted instructional program using graphics, color, and text in simulations to enhance pharmacy students' knowledge of microbiology and antimicrobial agents. Results indicated high short- and long-term retention of information presented and higher levels of knowledge and comprehension among these students (n=111) than others. (Author/MSE)

Published
1991

12. Candida glabrata fungemia: experience in a tertiary care center

Author

Malani, Anurag, Hmoud, Jareer, Chiu, Loretta, Carver, Peggy L., Bielaczyc, Andrew, and Kauffman, Carol A.

Subjects
Itraconazole -- Dosage and administration, Fluconazole -- Dosage and administration, Candidiasis -- Risk factors, Candidiasis -- Development and progression, Candidiasis -- Drug therapy, Health, Health care industry
Published
2005

18. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals

Author

Schneeweiss, Sebastian, primary, Carver, Peggy L, additional, Datta, Kausik, additional, Galar, Alicia, additional, Johnson, Melissa D, additional, Letourneau, Alyssa R, additional, Marty, Francisco M, additional, Nagel, Jerod, additional, Najdzinowicz, Maryann, additional, Saul, Melissa, additional, Schuster, Mindy, additional, Shoham, Shmuel, additional, Silveira, Fernanda P, additional, Varughese, Christy, additional, Wilck, Marissa, additional, Weatherby, Lisa, additional, Oene, Joop van, additional, and Walker, Alexander M, additional

Published
2019
Full Text
View/download PDF

28. From macrolides to ketolides: what is available for the treatment of outpatient respiratory tract infections?

Author

Carver, Peggy L.

Subjects
Erythromycin -- Dosage and administration, Erythromycin -- Genetic aspects, Ribosomal RNA -- Genetic aspects, Ethinyl estradiol -- Dosage and administration, Ethinyl estradiol -- Genetic aspects, Pharmaceutical industry -- Genetic aspects, Military-industrial complex -- Genetic aspects, Carbamates -- Genetic aspects, Isoenzymes -- Genetic aspects, Professional soccer -- Genetic aspects, Bacterial pneumonia -- Drug therapy, Bacterial pneumonia -- Genetic aspects, Pneumonia -- Drug therapy, Pneumonia -- Genetic aspects, Cytochrome P-450 -- Genetic aspects, Pediatrics -- Genetic aspects, Methylation -- Genetic aspects, Medical research -- Genetic aspects, Medicine, Experimental -- Genetic aspects, Chemotherapy -- Genetic aspects, Drug resistance in microorganisms -- Drug therapy, Drug resistance in microorganisms -- Genetic aspects, Antacids -- Dosage and administration, Antacids -- Genetic aspects, Cancer -- Chemotherapy, Cancer -- Genetic aspects, Health
Published
2002

33. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.

Author

Schneeweiss, Sebastian, Carver, Peggy L, Datta, Kausik, Galar, Alicia, Johnson, Melissa D, Letourneau, Alyssa R, Marty, Francisco M, Nagel, Jerod, Najdzinowicz, Maryann, Saul, Melissa, Schuster, Mindy, Shoham, Shmuel, Silveira, Fernanda P, Varughese, Christy, Wilck, Marissa, Weatherby, Lisa, Oene, Joop van, and Walker, Alexander M

Subjects
*HOSPITAL patients, *HEPATOCELLULAR carcinoma, *ELECTRONIC health records, *CARCINOGENICITY, *MORTALITY, *ANTIFUNGAL agents, *RESEARCH, *LIVER tumors, *TIME, *RESEARCH methodology, *RETROSPECTIVE studies, *MEDICAL cooperation, *EVALUATION research, *PARENTERAL infusions, *COMPARATIVE studies, *HOSPITAL care, *FUNGEMIA, *PROBABILITY theory
Abstract

Background: Liver tumours observed in rats exposed to micafungin led to a black box warning upon approval in Europe in 2008. Micafungin's risk for liver carcinogenicity in humans has not been investigated. We sought to describe the risk of fatal hepatocellular carcinoma (HCC) among persons who received micafungin and other parenteral antifungals (PAFs) with up to 12 years of follow-up.Methods: We assembled a US multicentre cohort of hospitalized patients who received micafungin or other PAFs between 2005 and 2012. We used propensity score (PS) matching on patient characteristics from electronic medical records to compare rates of HCC mortality identified through the National Death Index though to the end of December 2016. We computed HRs and 95% CIs.Results: A total of 40110 patients who received a PAF were identified; 6903 micafungin recipients (87% of those identified) were successfully matched to 16317 comparator PAF users. Ten incident HCC deaths, one in the micafungin-exposed group and nine among comparator PAF users, occurred in 71285 person-years of follow-up. The HCC mortality rate was 0.05 per 1000 person-years in micafungin patients and 0.17 per 1000 person-years in comparator PAF patients. The PS-matched HR for micafungin versus comparator PAF was 0.29 (95% CI 0.04-2.24).Conclusions: Both micafungin and comparator PAFs were associated with HCC mortality rates of <0.2 per 1000 person-years. Given the very low event rates, any potential risk for HCC should not play a role in clinical decisions regarding treatment with micafungin or other PAFs investigated in this study. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

37. Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study

Author

Schneeweiss, Sebastian, primary, Carver, Peggy L., additional, Datta, Kausik, additional, Galar, Alicia, additional, Johnson, Melissa D., additional, Johnson, Matthew G., additional, Marty, Francisco M., additional, Nagel, Jerod, additional, Najdzinowicz, Maryann, additional, Saul, Melissa, additional, Shoham, Shmuel, additional, Silveira, Fernanda P., additional, Varughese, Christy A., additional, Wilck, Marissa, additional, Weatherby, Lisa, additional, Auton, Tim, additional, and Walker, Alexander M., additional

Published
2016
Full Text
View/download PDF

39. Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

Author

Eschenauer, Gregory A., primary, Nguyen, M. Hong, additional, Shoham, Shmuel, additional, Vazquez, Jose A., additional, Morris, Arthur J., additional, Pasculle, William A., additional, Kubin, Christine J., additional, Klinker, Kenneth P., additional, Carver, Peggy L., additional, Hanson, Kimberly E., additional, Chen, Sharon, additional, Lam, Simon W., additional, Potoski, Brian A., additional, Clarke, Lloyd G., additional, Shields, Ryan K., additional, and Clancy, Cornelius J., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results